Literature DB >> 6102232

End-organ resistance to 1,25-dihydroxycholecalciferol.

U A Liberman, R Samuel, A Halabe, R Kauli, S Edelstein, Y Weisman, S E Papapoulos, T L Clemens, L J Fraher, J L O'Riordan.   

Abstract

A 13-year-old girl with total alopecia who in infancy had rickets unresponsive to large doses of vitamin D2 is described. She had profound hypocalcaemia which was resistant to treatment with high doses of dihydrotachysterol, 1 alpha-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol. Serum concentrations of 25-hydroxyvitamin D were normal but those of 1,25-dihydroxycholecalciferol were markedly raised (674 and 745 pg/ml). In addition, 24,25-dihydroxyvitamin D was undetectable in serum. Administration of synthetic 24,25-dihydroxycholecalciferol was followed by normocalcaemia which persisted long after treatment was stopped. Her sister, who died at the age of 10 months, also had had total alopecia, rickets, and hypocalcaemia resistant to vitamin-D2 therapy. In this familial syndrome there seems to be end-organ resistance to the action of 1,25-dihydroxycholecalciferol, possibly as a result of changes at the receptor sites.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6102232     DOI: 10.1016/s0140-6736(80)92763-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

Review 1.  Molecular genetics of mineral metabolic disorders.

Authors:  R V Thakker
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 2.  [Genetically induced hair diseases].

Authors:  T Wiederholt; P Poblete-Gutiérrez; J Frank
Journal:  Hautarzt       Date:  2003-07-04       Impact factor: 0.751

3.  Bone in the marmoset: a resemblance to vitamin D-dependent rickets, type II.

Authors:  A Yamaguchi; Y Kohno; T Yamazaki; N Takahashi; T Shinki; N Horiuchi; T Suda; H Koizumi; Y Tanioka; S Yoshiki
Journal:  Calcif Tissue Int       Date:  1986-07       Impact factor: 4.333

4.  Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3 in a patient without alopecia.

Authors:  L J Fraher; R Karmali; F R Hinde; G N Hendy; H Jani; L Nicholson; D Grant; J L O'Riordan
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

5.  The mechanism of end-organ resistance to 1 alpha,25-dihydroxycholecalciferol in the common marmoset.

Authors:  N Takahashi; S Suda; T Shinki; N Horiuchi; Y Shiina; Y Tanioka; H Koizumi; T Suda
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

6.  Two siblings with vitamin-D-dependent rickets type II: no recurrence of rickets for 14 years after cessation of therapy.

Authors:  E Takeda; I Yokota; I Kawakami; T Hashimoto; Y Kuroda; S Arase
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

7.  Inherited disorders of calcium and phosphate metabolism.

Authors:  Jyothsna Gattineni
Journal:  Curr Opin Pediatr       Date:  2014-04       Impact factor: 2.856

Review 8.  Blood levels of vitamin D metabolites in gonarthrosis.

Authors:  C Tauber; M Noff; D Noff; S Pitaru; C Malkin
Journal:  Arch Orthop Trauma Surg       Date:  1991       Impact factor: 3.067

9.  Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts.

Authors:  U A Liberman; C Eil; S J Marx
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

10.  Clinical and biochemical findings in parents of children with vitamin D-dependent rickets Type II.

Authors:  I Yokota; E Takeda; M Ito; H Kobashi; T Saijo; Y Kuroda
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.